The most commonly reported early symptoms include a noticeable reduction in appetite within 24 to 72 hours, mild fullness or bloating after meals, slight nausea, particularly if eating large or fatty meals, and changes in bowel habits such as softer stools or mild constipation
This caution is noted in the prescribing information
Antioxid Redox Signal, 2017
17 mg/mL: the niacinamide formulations Several pharmacies compound tirzepatide at 17 mg/mL, often combined with 2 mg/mL of niacinamide
A meta-analysis revealed that a 2.4 mg dose of semaglutide led to a reduction of 12.4 kg of body weight, while doses of 3.0 mg of liraglutide, 1.0 mg of semaglutide, and 1.8 mg of liraglutide led to reductions in body weight of 5.2 kg, 3.7 kg, and 1.8 kg, respectively
10.1007/s00438-004-1006-8 Mol